M. Sieber
German Hodgkin's Lymphoma Study Group
Klinik für Innere Medizin
University of Cologne
Germany
Name/email consistency: high
- 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber, M., Bredenfeld, H., Josting, A., Reineke, T., Rueffer, U., Koch, T., Naumann, R., Boissevain, F., Koch, P., Worst, P., Soekler, M., Eich, H., Müller-Hermelink, H.K., Franklin, J., Paulus, U., Wolf, J., Engert, A., Diehl, V. J. Clin. Oncol. (2003)









